key: cord-0693904-fcr6kauk
authors: Kriger, Or; Gefen-Halevi, Shiraz; Leshem, Eyal; Smollan, Gillian; Belausov, Natasha; Egbarye, Aseel; Khashab, Rawan; Odeh, Miran; Saffia, Adleen; Barak, Yuval; Hussein, Oswa Abu; Hamias, Rachel; Aharon, Yael; Alfandari, Jacqueline; Nemet, Ital; Kliker, Limor; Sherbany, Hilda; Mandelboim, Michal; Amit, Sharon
title: Viral co-pathogens in COVID-19 acute respiratory syndrome – what did we learn from the first year of pandemic?
date: 2022-01-14
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2022.01.018
sha: e62a00e415586bdac30db110a5c86b35f93f11a9
doc_id: 693904
cord_uid: fcr6kauk

Objective : To describe the distribution of respiratory pathogens and the occurrence of co-pathogens during the first year of the COVID-19 pandemic. Methods : We used a multiplex-PCR panel targeting 23 microorganisms to analyze oro-pharyngeal samples of patients admitted to our hospital with acute respiratory infection (ARI) between March 1st 2020 and February 28th 2021. We age and sex matched 40-50 SARS-CoV-2 positive and negative patients per month. Results : A total of 939 patients with multiplex-PCR test results included in the study. Respiratory pathogens where detected in only 8/476 (1.6%) COVID-19 versus 87/463 (18.7%) non-COVID-19 ARI patients. Diversity and rates of pathogens vastly differed from previous years yet showed seasonal variance. Conclusion : SARS-CoV-2 patients presenting with ARI during the first COVID-19 pandemic year demonstrated paucity of respiratory co-pathogens.

To describe the distribution of respiratory pathogens and the occurrence of copathogens during the first year of the COVID-19 pandemic.

Methods:

We used a multiplex-PCR panel targeting 23 microorganisms to analyze oropharyngeal samples of patients admitted to our hospital with acute respiratory infection (ARI) between March 1st 2020 and February 28th 2021. We age and sex matched 40-50 SARS-CoV-2 positive and negative patients per month.

A total of 939 patients with multiplex-PCR test results included in the study. Keywords: COVID-19, SARS-CoV-2, co-infections

Acute infectious respiratory illness (ARI) is a substantial contributor to global morbidity and mortality (GBD 2016 Lower Respiratory Infections Collaborators, 2018 . During COVID-19 pandemic, a major decrease in the incidence of respiratory infectious diseases was noted in countries where non-pharmaceutical measures as masks, school closure and social distancing were taken to mitigate the pandemic (Lee and Lin, 2020) . Occurrence of bacterial co-pathogens or secondary infections is well described in the context of severe COVID-19 (Langford et al., 2020; Patel et al., 2021) , contributing to grave prognosis of patients with severe disease. The cooccurrence of viral and atypical pathogens in COVID-19 was reported to be 11.6%

(pooled prevalence) in one meta-analysis (Davis et al., 2020) , but the studies addressing this topic are methodologically diverse. The effects of the introduction of the SARS-CoV-2 to the oral microbiota are only partially studied, yet bacterial composition does not seem to be substantially altered (Braun et al., 2021) . As the pandemic progressed in both southern and northern hemispheres, an almost universal decrease of major viral pathogens was reported (Lee and Lin, 2020; Soo et al., 2020) . The BioFire is a sample-to-result, multiplex, nested-PCR platform allowing rapid coronaviruses, RSV and influenza that practically disappeared that winter (Figure 1a and 1b, Supplementary Table 3) .

In this study, we report the paucity of respiratory co-pathogens detected in COVID-19 patients presenting with ARI compared with the background rates of respiratory pathogens in non-COVID-19 ARI patients. We observed seasonal changes both in respiratory pathogens incidence and variety (Supplementary Table 3 Unlike other reports addressing co-pathogen occurrence in COVID-19 patients (Chen et al., 2020; Kim et al., 2020 Kim et al., , 2021 Thelen et al., 2021) This study has several limitations. Although all attempts were made to create a calendric-balanced data set of SARS-CoV-2 positive and negative patients, in some disease nadir months we could not reach the 50 patients required. In addition, generalizability of the study is limited with regards to the younger age groups as matching criteria could not be fulfilled due to paucity of pediatric COVID-19 patients.

Likewise, this is a single-center study, representing merely an annual local epidemiology of a unique year. Further surveillance is needed to assess the effects of SARS-CoV-2 on the personal and societal virome.

In conclusion, the annual rates of co-pathogens in Israeli COVID-19 patients with ARI were low compared with the background rates of respiratory pathogens in SARS-CoV-2 negative ARI patients. The appearance patterns of the various pathogens diverged from previous years and along the study period, with human rhinovirus being the prominent non-SARS-CoV-2 pathogen. Further studies should address the impact of SARS-CoV-2 presence per-se on the co-occurrence of other respiratory pathogens seasonality and diversity. Such data are of major importance for policy makers with regards to surveillance, acute illness diagnostics and infection control.

Funding: This study received no external funding.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: 10000 12000 01-03-2020 08-03-2020 15-03-2020 22-03-2020 29-03-2020 05-04-2020 12-04-2020 19-04-2020 26-04-2020 03-05-2020 10-05-2020 17-05-2020 24-05-2020 31-05-2020 07-06-2020 14-06-2020 21-06-2020 28-06-2020 05-07-2020 12-07-2020 19-07-2020 26-07-2020 02-08-2020 09-08-2020 16-08-2020 23-08-2020 30-08-2020 06-09-2020 13-09-2020 20-09-2020 27-09-2020 04-10-2020 11-10-2020 18-10-2020 25-10-2020 01-11-2020 08-11-2020 15-11-2020 22-11-2020 29-11-2020 06-12-2020 13-12-2020 20-12-2020 

SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Viral and atypical respiratory co-infections in COVID-19: a systematic review and metaanalysis

The interseasonal resurgence of Respiratory Syncytial Virus in Australian children following the reduction of Coronavirus disease 2019-related public health measures

Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study

Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens

Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Effects of COVID-19 Prevention Measures on Other Common Infections

Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria

Decreased Influenza Incidence under COVID-19 Control Measures

Community-acquired bacteraemia in COVID-19 in comparison to influenza A and influenza B: a retrospective cohort study

Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures